VITAMIN D DEFICIENCY IN PATIENTS WITH ACUTE CORONARY SYNDROME

Aim. To assess vitamin D level in patients with acute coronary syndrome and to determine the relationships of vitamin D level with specific patterns of cardiovascular disease in this group of patients.

Methods. 50 patients (35 (70%) males and 15 (30%) females) urgently admitted to the emergency cardiology department of Kaliningrad Regional Hospital were enrolled in the cross-sectional observational study. Patients with diabetes mellitus, autoimmune diseases and cancer were excluded from the study. The mean age of patients was 60 (55; 66) years. Cardiovascular risk factors (obesity, smoking, physical activity, alcohol consumption, genetic predisposition) were assessed in all patients. Total serum cholesterol levels, GFR (CKD-EPI) and troponin levels were measured in all participants. Echocardiography included the measurement of the left ventricular mass index. Coronary angiography with omnipaque contrast was performed in all cases. 25-OH vitamin D was measured with enzyme-linked immunosorbent assay (ELISA).

Results. The majority of patients with acute coronary syndrome had vitamin D deficiency. 3 (6%) patients had severe vitamin D deficiency. The subgroup of patients with marked vitamin D deficiency (n = 39) more often had elevated blood pressure probably related to the left ventricular hypertrophy and left atrial enlargement. Left ventricular systolic dysfunction and occlusive coronary artery disease were more common in patients with lower vitamin D levels. Statistically significant correlations had not been found between vitamin D levels and cardiovascular risk factors as well as laboratory data.

Conclusion. Vitamin D level below normal range was detected in the vast majority of patients with acute coronary syndrome, of them 6 % of patients had critically low vitamin D levels.

1. Benjamin E.J., Virani S.S., Callaway C.W., Chamberlain A.M., Chang A.R., Cheng S. et al. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018;137:e67-e492. doi: 10.1161/ CIR.0000000000000558.

2. Pilz S., Gaksch M., Kienreich K., Grübler M., Verheyen N., Fahrleitner-Pammer A. et al. Effects of Vitamin D on Blood Pressure and Cardiovascular Risk Factors. Hypertension. 2015;65:11951201. doi: 10.1161/HYPERTENSIONAHA.115.05319

3. Hutchinson M.S., Grimnes G., Joakimsen R.M., Figenschau Y., Jorde R. Low serum 25- hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study. Eur J Endocrinol 2010;162:935-42. doi: 10.1530/EJE-09-1041

4. Liu L, Chen M, Hankins SR, et al. Serum 25-Hydroxyvitamin D Concentration and Mortality From Heart Failure and Cardiovascular Disease, and Premature Mortality from All Cause in United States Adults. Am J Cardiol. 2012;1 10(6): 834-9. doi: 10.1016/j.amjcard.2012.05.013.

5. de Boer I.H., Levin G., Robinson-Cohen C., Biggs M.L., Hoofnagle A.N., Siscovick D.S., Kestenbaum B. Serum 25-hydroxyvitamin d concentration and risk for major clinical disease events in a community-based population of older adults: a cohort study. Ann Intern Med 2012;156:627-34. doi: 10.7326/0003-4819-156-9-201205010-00004.

6. Kestenbaum B., Katz R., de Boer I., Hoofnagle A., Sarnak M.J., Shlipak M.G., Jenny N.S., Siscovick D.S. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 2011;58:1433-41. doi: 10.1016/j.jacc.2011.03.069.

7. Melamed M.L., Michos E.D., Post W., Astor B. 25-Hydroxyvitamin d levels and the risk of mortality in the general population. Arch Intern Med.2008;168:1629 –1637. doi: 10.1001/archinte.168.15.1629.

8. Dobnig H., Pilz S., Scharnagl H., Renner W., Seelhorst U., Wellnitz B., Kinkeldei J., Boehm B.O., Weihrauch G., Maerz W. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-9. doi: 10.1001/ archinte.168.12.1340.

9. Robinson-Cohen C., Hoofnagle A.N., Ix J.H., Sachs M.C., Tracy R.P., Siscovick D.S., Kestenbaum B.R., de Boer I.H. Racial differences in the association of serum 25-hydroxyvitamin D concentration with coronary heart disease events. JAMA 2013;310:179-88. doi: 10.1001/jama.2013.7228.

10. Geovanini G.R., Libby P. Atherosclerosis and inflammation: overview and updates. Clinical Science (2018) 132 1243–1252. doi: 10.1042/CS20180306.

11. Yin, K. Agrawal D. K. Vitamin D and inflammatory diseases J. Inflamm. Res. 2014;7:69-87. doi: 10.2147/JIR.S63898

12. Kassi E., Adamopoulos C., Basdra E.K., Papavassiliou A.G. Role of vitamin D in atherosclerosis. Circulation. 2013;128(23):2517-2531.

13. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R.; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13

14. Kienreich K., Grubler M., Tomaschitz A., Schmid J., Verheyen N., Rutters F., Dekker J.M., Pilz S. Vitamin D, arterial hypertension & cerebrovascular disease Indian J Med Res. 2013;137:669–679

15. Kunutsor S.K., Apekey T.A., Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol. 2013;28:205–221. doi: 10.1007/s10654-013-9790-2.

16. Li Y.C. Vitamin D regulation of the renin-angiotensin system. J. Cell. Biochem. 2003; 88(2), 327–331

17. Deficit vitamina D u vzroslyh: diagnostika, lechenie i profilaktika. Klinicheskie rekomendacii Rossijskoj associacii endokrinologov. Moscow; 2015. (In Russian)

18. Roth D.E., Abrams S.A., Aloia J., Bergeron G., Bourassa M.W., Brown K.H., Calvo M.S., Cashman K.D., Combs G., DeRegil L.M., Jefferds M.E., Jones K.S., Kapner H., Martineau A.R., Neufeld L.M., Schleicher R.L., Thacher T.D., Whiting S.J. Global prevalence and disease burden of vitamin D deficiency: a roadmap for action in low- and middle-income countries. Ann N Y Acad Sci. 2018;1430(1):44-79. doi: 10.1111/nyas.13968.

19. Safi A.T., Orazov M.R., Kalinchenko S.Yu. The level of vitamin D in women of different age groups. Research'n Practical Medicine Journal. 2018;5 (S1):70. doi: 10.17709/2409-22312018-5-S1.(In Russian)

20. Arutyunyan T.M.1, Kasyanova A.N.1, Aksenov A.G.1 Vitamin D levels and indicators of calcium and phosphorus metabolism of young children, living in the south of Russia. Health and Education in the XXI Century. 2015;17(2):78-82. (In Russian)

21. Karonova T.L., Grinyova E.N., NikitiM I.L., Tsvetkova E.V., Todieva A.M., Belyaeva O.D., Mikheeva E.P., Globa P. Yu., Andreeva A.T., Beletskaya I.S., Omelchuk N.V., Fulonova L.S., Shlyakhto E.V.The prevalence of vitamin d deficiency in the northwestern region of the russian federation among the residents of St. Petersburg and Petrozavodsk. Osteoporosis and Bone Diseases 2013;(3):3-7. (In Russian) doi: https://doi. org/10.14341/osteo201333-7

22. Wacker, M., & Holick, M. F. Sunlight and Vitamin D: A global perspective for health. Dermato-endocrinology. 2013;5(1):51–108. doi: 10.4161/derm.24494.

23. Povoroznyuk V.V., Snezhickij V.A., YAnkovskaya L.V., Majlyan E.A., Reznichenko N.A., Majlyan D.E. Znachenie vitamina D v patogeneze serdechno-sosudistyh zabolevanij. ZHurnal Grodnenskogo gosudarstvennogo medicinskogo universiteta. 2015;2(50):6-14. (In Russian)

24. Danik, J. S., Manson, J. E. Vitamin d and cardiovascular disease. Curr Treat Options Cardiovasc Med. 2012;14(4):414– 424. doi: 10.1007/s11936-012-0183-8

25. Barbarash N.A., Kuvshinov D.Y. NUTRITION AND CARDIOVASCULAR HEALTH. Complex Issues of Cardiovascular Diseases. 2017;(2):87-92. (In Russian) https:// doi.org/10.17802/2306-1278-2017-2-87-92

26. Gotlieb A.I. Atherosclerosis and acute coronary syndromes. Cardiovasc Pathol. 2005;14(4):181-4. doi: 10.1016/j.carpath.2005.03.007

27. Menezes A.R., Lamb M.C., Lavie C.J., DiNicolantonio J.J. Vitamin D and atherosclerosis. Curr Opin Cardiol. 2014;29(6):571-7. doi: 10.1097/HCO.0000000000000108.

28. Wong B.W., Meredith A., Lin D., McManus B.M. The biological role of inflammation in atherosclerosis. Can J Cardiol. 2012;28(6):631-41. doi: 10.1016/j.cjca.2012.06.023.

29. Libby, P., Ridker, P. M., Hansson, G. K., & Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol.. 2009;54(23):2129-2138. doi: 10.1016/j.jacc.2009.09.009

30. Cannell, J. J., Grant, W. B., & Holick, M. F. Vitamin D and inflammation. Dermato-endocrinology. 2015;6(1):e983401. doi: 10.1007/s00467-012-2377-4.

31. Miraglia Del Giudice M, Indolfi C, Strisciuglio C. Vitamin D: Immunomodulatory Aspects. J Clin Gastroenterol. 2018;52(suppl 1):86-88. doi: 10.1097/MCG.0000000000001112.

32. Karur S., Veerappa V., Nanjappa M.C. Study of vitamin D deficiency prevalence in acute myocardial infarction. Int J Cardiol Heart Vessel. 2014;3: 57–59. doi: 10.1016/j.ijchv.2014.03.004

33. Pilz S., März W., Wellnitz B., Seelhorst U., Fahrleitner-Pammer A., Dimai H.P., Boehm B.O., Dobnig H. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large crosssectional study of patients referred for coronary angiography. J Clin Endocrinol Metab. 2008;93:3927-3935. doi: 10.1210/jc.2008-0784.

34. Milazzo V., De Metrio M., Cosentino N., Marenzi G., Tremoli E.. Vitamin D and acute myocardial infarction. World J Cardiol. Jan 26, 2017; 9(1): 14-20. doi: 10.4330/wjc.v9.i1.14

35. Naesgaard Patrycja A., León de la Fuente Ricardo A., Nilsen Stein Tore et al. Suggested Cut-Off Values for Vitamin D as a Risk Marker for Total and Cardiac Death in Patients with Suspected Acute Coronary Syndrome. Front Cardiovasc Med. 2016; 3: 4. doi: 10.3389/fcvm.2016.00004